mda-mb-468 glutathione content

mda-mb-468 glutathione content Mutant p53 reactivators protect breast cancer cells from ferroptosis - Rathnayake - 2024 - Cell Biochemistry and Function Frontiers | Dihydroartemisinin-Transferrin Adducts Enhance

Name: mda-mb-468 glutathione content Mutant p53 reactivators protect breast cancer cells from ferroptosis - Rathnayake - 2024 - Cell Biochemistry and Function Frontiers | Dihydroartemisinin-Transferrin Adducts Enhance
Brand: msw-creativ-solutions.de
SKU: 1783585555
Price: 21.93 USD
Availability: InStock
Rating: 4.2502 (29 reviews)

Frontiers Dihydroartemisinin Transferrin Adducts Enhance TRAIL Induced Apoptosis in Triple Negative Breast Cancer in a P53 Independent and ROS Dependent Manner MDA MB 468 (DMEM) Cell Complete Medium MDA MB 468 Luciferase Reporter Cell Line AcceGen MDA MB 468 Cell Line an overview ScienceDirect Topics Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD L1 in Triple Negative Breast Cancer Cells Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Scientific Reports

SKU: 1783585555 · From msw-creativ-solutions.de

4.3

USD21.93 USD43.93

Pay in 4 interest-free payments of $5.48 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 20 - Sep 25

Description

Franklin, G

1I) and the ratio of GSH/GSSG (Fig

J.ChungT

Faseb J 15(2): 306-308

Sections were washed with PBS and then incubated with Alexa Fluor 488-conjugated goat anti-mouse IgG (1: 1000

Research on MOTS-c in ovariectomized mice (a model for postmenopausal metabolic dysfunction) showed reduced fat accumulation in white adipose tissue, increased brown fat activation, and improved insulin sensitivity after just 5 weeks of treatment